Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00811317 · ClinicalTrials.gov registry record · NA
Closed-loop Glucose Control for Automated Management of Type 1 Diabetes
A NA study, sponsored by Boston University Charles River Campus.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT00811317 is a NA study that has completed, run by Boston University Charles River Campus. The registered enrollment target is 11 participants.
The verdict
NCT00811317, a NA study, has completed, sponsored by Boston University Charles River Campus.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
We hypothesize that our integrated closed-loop glucose-control system can provide effective, tight, and safe blood glucose (BG) control in type 1 diabetes, thereby establishing the feasibility of closed-loop BG control.
Interventions
- DEVICE Closed-loop
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00811317
The ClinicalTrials.gov registry entry for NCT00811317 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University Charles River Campus, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Closed-loop is the first listed.
NCT00811317 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00811317 about?
NCT00811317 is a clinical study titled "Closed-loop Glucose Control for Automated Management of Type 1 Diabetes". We hypothesize that our integrated closed-loop glucose-control system can provide effective, tight, and safe blood glucose (BG) control in type 1 diabetes, thereby establishing the feasibility of closed-loop BG control.
What is the current status of trial NCT00811317?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2008-05. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00811317?
The interventions under investigation include: Closed-loop (DEVICE).
Who is sponsoring clinical trial NCT00811317?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.